Pegvisomant for the Treatment of gsp-Mediated Growth Hormone Excess in Patients with McCune-Albright Syndrome [PDF]
Sunday O. Akintoye +7 more
openalex +1 more source
Cabergoline-Induced Gambling Causing Increased Adrenal Crisis Episodes. [PDF]
Martinez-Gil M +3 more
europepmc +1 more source
Prognosis value of pituitary neuroendocrine tumor volume. [PDF]
Yang JS.
europepmc +1 more source
Lowering Total Plasma Insulin-Like Growth Factor I Concentrations by Way of a Novel, Potent, and Selective Growth Hormone (GH) Receptor Antagonist, Pegvisomant (B2036-Peg), Augments the Amplitude of GH Secretory Bursts and Elevates Basal/Nonpulsatile GH Release in Healthy Women and Men1 [PDF]
Johannes D. Veldhuis +4 more
openalex +1 more source
Lipodystrophy during pegvisomant therapy: a case report and review of the literature
D Buyuktas +3 more
doaj +1 more source
Growth Hormone Upregulates Melanoma Drug Resistance and Migration via Melanoma-Derived Exosomes. [PDF]
Kulkarni P +5 more
europepmc +1 more source
Case Report: Bilateral lens dislocation as an atypical presentation of acromegaly and review of the ocular effects of GH/IGF-1 excess. [PDF]
Vitale L +6 more
europepmc +1 more source
A Review on Coexisting Giants: The Interplay Between Acromegaly and Diabetes Mellitus. [PDF]
Aggarwal S +4 more
europepmc +1 more source
Brazilian multicenter study on pegvisomant treatment in acromegaly
César Luiz Boguszewski +14 more
openalex +1 more source

